| Dr Deedee T Diep, DO | |
|
3000 Hospital Blvd, 2nd Floor, Roswell, GA 30076-4915 | |
| (770) 751-2777 | |
| (770) 751-2773 |
| Full Name | Dr Deedee T Diep |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 13 Years |
| Location | 3000 Hospital Blvd, Roswell, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033499942 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 071487 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital Cherokee | Canton, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| North Atlanta Professional Services Llc | 0840291944 | 296 |
News Archive
QIAGEN completed the acquisition through a tender offer and subsequent merger of Digene with and into a wholly owned subsidiary of QIAGEN. At the completion of the merger, Digene will become a wholly owned subsidiary of QIAGEN's affiliate QIAGEN North American Holdings, Inc.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium, the Technical University of Munich, and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same mutation in precursor cells of the pancreas or the bile duct leads to fundamental different outcomes.
How should we handle the new CRISPR technology that can both advance science and medicine, but also be used to make designer babies? Scientist and author Paul Knoepfler tackles this and other difficult questions related to this revolutionary technology in his new book, GMO Sapiens: The Life-Changing Science of Designer Babies, targeted at a broad, lay audience.
› Verified 5 days ago
| Entity Name | Hospital Physician Services - Southeast Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760410385 PECOS PAC ID: 5597774554 Enrollment ID: O20060419000545 |
News Archive
QIAGEN completed the acquisition through a tender offer and subsequent merger of Digene with and into a wholly owned subsidiary of QIAGEN. At the completion of the merger, Digene will become a wholly owned subsidiary of QIAGEN's affiliate QIAGEN North American Holdings, Inc.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium, the Technical University of Munich, and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same mutation in precursor cells of the pancreas or the bile duct leads to fundamental different outcomes.
How should we handle the new CRISPR technology that can both advance science and medicine, but also be used to make designer babies? Scientist and author Paul Knoepfler tackles this and other difficult questions related to this revolutionary technology in his new book, GMO Sapiens: The Life-Changing Science of Designer Babies, targeted at a broad, lay audience.
› Verified 5 days ago
| Entity Name | North Atlanta Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316959869 PECOS PAC ID: 0840291944 Enrollment ID: O20070116000197 |
News Archive
QIAGEN completed the acquisition through a tender offer and subsequent merger of Digene with and into a wholly owned subsidiary of QIAGEN. At the completion of the merger, Digene will become a wholly owned subsidiary of QIAGEN's affiliate QIAGEN North American Holdings, Inc.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium, the Technical University of Munich, and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same mutation in precursor cells of the pancreas or the bile duct leads to fundamental different outcomes.
How should we handle the new CRISPR technology that can both advance science and medicine, but also be used to make designer babies? Scientist and author Paul Knoepfler tackles this and other difficult questions related to this revolutionary technology in his new book, GMO Sapiens: The Life-Changing Science of Designer Babies, targeted at a broad, lay audience.
› Verified 5 days ago
| Entity Name | Phoebe Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487899464 PECOS PAC ID: 8426112350 Enrollment ID: O20090121000583 |
News Archive
QIAGEN completed the acquisition through a tender offer and subsequent merger of Digene with and into a wholly owned subsidiary of QIAGEN. At the completion of the merger, Digene will become a wholly owned subsidiary of QIAGEN's affiliate QIAGEN North American Holdings, Inc.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium, the Technical University of Munich, and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same mutation in precursor cells of the pancreas or the bile duct leads to fundamental different outcomes.
How should we handle the new CRISPR technology that can both advance science and medicine, but also be used to make designer babies? Scientist and author Paul Knoepfler tackles this and other difficult questions related to this revolutionary technology in his new book, GMO Sapiens: The Life-Changing Science of Designer Babies, targeted at a broad, lay audience.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Deedee T Diep, DO 3000 Hospital Blvd, 2nd Floor, Roswell, GA 30076-4915 Ph: (770) 751-2777 | Dr Deedee T Diep, DO 3000 Hospital Blvd, 2nd Floor, Roswell, GA 30076-4915 Ph: (770) 751-2777 |
News Archive
QIAGEN completed the acquisition through a tender offer and subsequent merger of Digene with and into a wholly owned subsidiary of QIAGEN. At the completion of the merger, Digene will become a wholly owned subsidiary of QIAGEN's affiliate QIAGEN North American Holdings, Inc.
Lotus Pharmaceuticals, Inc.a fast-growing, profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China announced today that its wholly owned subsidiary, En Ze Jia Shi Pharmaceuticals, has been issued a patent by the State Intellectual Property Office of the People's Republic of China for controlled-release oral gliclazide. The patent covers the composition and preparation methods for the drug through 2030.
Why do alterations of certain genes cause cancer only in specific organs of the human body? Scientists at the German Cancer Consortium, the Technical University of Munich, and the University Medical Center Göttingen have now demonstrated that cells originating from different organs are differentially susceptible to activating mutations in cancer drivers: The same mutation in precursor cells of the pancreas or the bile duct leads to fundamental different outcomes.
How should we handle the new CRISPR technology that can both advance science and medicine, but also be used to make designer babies? Scientist and author Paul Knoepfler tackles this and other difficult questions related to this revolutionary technology in his new book, GMO Sapiens: The Life-Changing Science of Designer Babies, targeted at a broad, lay audience.
› Verified 5 days ago
Amy L Barfield, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2500 Hospital Blvd Ste 130, Roswell, GA 30076 Phone: 770-740-1753 Fax: 770-740-8503 | |
Ms. Suzanne Jeannette Ferree, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 11660 Alpharetta Hwy Ste 290, Roswell, GA 30076 Phone: 404-446-3600 Fax: 404-446-3609 | |
Dr. Kumuda Ranjan, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 9420 Willeo Rd, Roswell, GA 30075 Phone: 404-439-9851 Fax: 404-994-5765 | |
Dr. Sima Dehghany, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1360 Upper Hembree Rd Ste 100, Roswell, GA 30076 Phone: 470-956-4430 | |
Dr. Rhett Bergeron, M.D Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 Sun Valley Dr, Suite D, Roswell, GA 30076 Phone: 678-990-5401 Fax: 678-900-5405 | |
Dr. Rina Eisenstein, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 215 Arbor Creek Way, Roswell, GA 30076 Phone: 404-324-7870 |